Skip to main content

Table 1 Summary of the mechanisms by which T2DM negatively affects the bone

From: The impact of type 2 diabetes on bone metabolism

 

Mechanisms

Effects on bone

AGEs

Osteoclastogenesis and osteoblast dysfunction [28]

Low bone quality [29, 30]

Increased risk of fragility fracture [28]

Insulin and IGF-1

Increases osteoblast proliferation and promotes collagen synthesis [38]

Negative correlation with hip and vertebral fracture [39]

PPARγ

Differentiate MSC into adipocytes [42]

Suppression of osteoblastogenesis [43]

Enteric hormones (incretins)

Energy intake releases GIP and GLP-2 [47,48,49,50]

Low incretin levels decrease bone formation and augment resorption [47,48,49,50]

Osteocalcin

Low levels in T2DM [54]

Low levels decrease bone formation [57, 58]

Wnt/B-catenin pathway: sclerostin

High levels in T2DM [59]

High sclerostin levels increase bone resorption [59]

Vitamin D3

Low levels in T2DM [31]

Reduction of 1,25(OH)2D3 receptors [61]

Reduction of osteocalcin synthesis [61]

  1. The indirect and direct effects of compromised glucose/insulin metabolism on bone induces a decreased bone turnover, a reduced bone quality and an augmented risk of fractures
  2. AGEs advanced glycation end-products, IGF-1 insulin-like growth factor-1, PPARγ peroxisome proliferator-activated receptor gamma, MSC mesenchymal stem-cells, GIP glucose-dependent insulinotropic polypeptide, GLP-2 glucagon-like peptide-2, T2DM type 2 diabetes mellitus, 1,25(OH) 2 D3 1,25 dihydroxy vitamin D